Carolyn E. Taylor - 21 Aug 2025 Form 4 Insider Report for Tonix Pharmaceuticals Holding Corp. (TNXP)

Role
Director
Signature
/s/ Jessica Morris as attorney-in-fact
Issuer symbol
TNXP
Transactions as of
21 Aug 2025
Net transactions value
+$15,061
Form type
4
Filing time
21 Aug 2025, 17:22:56 UTC
Previous filing
15 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Taylor Carolyn E. Director C/O TONIX PHARMACEUTICALS HOLDING CORP., 26 MAIN STREET, SUITE 101, CHATHAM /s/ Jessica Morris as attorney-in-fact 21 Aug 2025 0001875324

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNXP Common Stock, par value $0.001 Purchase $15,061 +418 $36.03 418 21 Aug 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average purchase price. Actual purchase prices ranged from $35.98 to $36.05.